SEC Company Response from Sintx Technologies, Inc. (SINT) (CIK 0001269026) (SINT) — Feb 7, 2014
Sintx Technologies, Inc. (SINT) (CIK 0001269026)
Date: Feb. 7, 2014 · CIK: 0001269026 · Accession: 0001193125-14-040665
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-192232
Letter
Acceleration Request - Company
Amedica Corporation
1885 West 2100 South
Salt Lake City, Utah 84119
February 7, 2014
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 3561
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ted Moskovitz
Re: Amedica Corporation
Registration Statement on Form S-1
File No. 333-192232
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Amedica Corporation, a Delaware corporation (the “Registrant”), hereby respectfully requests that the effective date of the above-captioned registration statement on Form S-1 (File No. 333-192232) be accelerated so that the registration statement may become effective at 5:00 p.m., Eastern time, on February 11, 2014, or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff. This request for acceleration is subject, however, to your receiving a telephone call prior to such time from our legal counsel, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., confirming this request. The Registrant hereby authorizes each of Daniel T. Kajunski and Anthony E. Hubbard of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, to make such request on its behalf.
The Registrant hereby acknowledges that:
(i) should the U.S. Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
(ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
(iii) the Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Please call Daniel T. Kajunski (617-542-1715) or Anthony E. Hubbard (617-542-1706) of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, with any comments or questions regarding this matter.
Very truly yours,
Amedica Corporation
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request - Company Amedica Corporation 1885 West 2100 South Salt Lake City, Utah 84119 February 7, 2014 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Mail Stop 3561 100 F Street, N.E. Washington, D.C. 20549 Attention: Ted Moskovitz Re: Amedica Corporation Registration Statement on Form S-1 File No. 333-192232 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Amedica Corporation, a Delaware corporation (the “Registrant”), hereby respectfully requests that the effective date of the above-captioned registration statement on Form S-1 (File No. 333-192232) be accelerated so that the registration statement may become effective at 5:00 p.m., Eastern time, on February 11, 2014, or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff. This request for acceleration is subject, however, to your receiving a telephone call prior to such time from our legal counsel, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., confirming this request. The Registrant hereby authorizes each of Daniel T. Kajunski and Anthony E. Hubbard of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, to make such request on its behalf. The Registrant hereby acknowledges that: (i) should the U.S. Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; (ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and (iii) the Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Please call Daniel T. Kajunski (617-542-1715) or Anthony E. Hubbard (617-542-1706) of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, with any comments or questions regarding this matter. Very truly yours, Amedica Corporation By: /s/ Kevin Ontiveros Name: Kevin Ontiveros Title: Chief Legal Officer cc: Securities and Exchange Commission Amanda Ravitz, Assistant Director Ted Mozkovitz Amedica Corporation Eric K. Olson Jay M. Moyes Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Daniel T. Kajunski Anthony E. Hubbard Cooley LLP Darren K. DeStefano